The University of Chicago Header Logo

Measurable Residual Disease and Decision-Making in Multiple Myeloma.

Measurable Residual Disease and Decision-Making in Multiple Myeloma. Hematol Oncol Clin North Am. 2024 Apr; 38(2):477-495.

View in: PubMed